Fluad Quadrivalent
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $20,077 | 921 | 853 |
| 2022 | $33,444 | 1,105 | 1,033 |
| 2021 | $164,933 | 466 | 348 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $162,261 | 115 | 74.3% |
| Food and Beverage | $40,741 | 2,371 | 18.6% |
| Honoraria | $14,659 | 4 | 6.7% |
| Travel and Lodging | $792.82 | 2 | 0.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 3, Randomized, Observer-blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine in Comparison With a Licensed Quadrivalent Influenza Vaccine, in Adults 50 to 64 Years of Age | Seqirus USA Inc | $159,261 | 0 |
| This phase 3 clinical study is a randomized, observer-blind, multicenter study of QIVc versus a non-influenza vaccine in subjects 6 months though 47 months of age. The purpose of this study is to evaluate efficacy of QIVc in the prevention of Reverse transcription polymerase chain reaction (RT-PCR) confirmed influenza A or B disease in children 6 through 47 months of age, compared to a non-influenza vaccine | Seqirus USA Inc | $3,000 | 1 |
Top Doctors Receiving Payments for Fluad Quadrivalent — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Nicole Koch | Medical | Kensington, MD | $41.80 | 3 |
| , PA-C | Physician Assistant | Silver Spring, MD | $41.79 | 3 |
| , M.D | Family Medicine | Silver, MD | $41.79 | 3 |
| , MD | Family Medicine | Ridgefield, CT | $41.73 | 2 |
| Sarah Balla | Family | Perryopolis, PA | $41.63 | 2 |
| Sanatkumar Shroff | — | Perryopolis, PA | $41.62 | 2 |
| , FNP | Internal Medicine | Tewksbury, MA | $41.53 | 2 |
| , M.D | Internal Medicine | Encinitas, CA | $41.26 | 2 |
| , NP | Registered Nurse | Troy, NY | $41.10 | 2 |
| , M.D | Family Medicine | Rochester, NY | $40.52 | 2 |
| , DO | Family Medicine | Dayton, OH | $40.48 | 2 |
| , MD | Family Medicine | Puyallup, WA | $40.39 | 2 |
| , D.O | Family Medicine | Schaefferstown, PA | $39.88 | 2 |
| , D.O | Family Medicine | Schaefferstown, PA | $39.87 | 2 |
| , M.D | Internal Medicine | San Jose, CA | $39.60 | 2 |
| , P.A.-C | Physician Assistant | Dayton, OH | $39.52 | 2 |
| , MD | Internal Medicine | Poway, CA | $39.47 | 2 |
| Carter Pieper | Physician Assistant | Chattanooga, TN | $39.29 | 2 |
| , PA-C | Medical | The Woodlands, TX | $39.03 | 2 |
| , P.A | Medical | Van Wert, OH | $38.70 | 2 |
| , M.D | Family Medicine | Nashville, TN | $38.57 | 2 |
| , M.D | Internal Medicine | Chicago, IL | $38.54 | 2 |
| , D.O | Student in an Organized Health Care Education/Training Program | Chico, CA | $38.54 | 2 |
| , MD | Internal Medicine | Poway, CA | $38.53 | 2 |
| , MSN, CNP, FNP-BC | Family | Bellefontaine, OH | $38.51 | 2 |
Manufacturing Companies
- Seqirus USA Inc $218,454
Product Information
- Type Biological
- Total Payments $218,454
- Total Doctors 2,078
- Transactions 2,492
About Fluad Quadrivalent
Fluad Quadrivalent is a biological associated with $218,454 in payments to 2,078 healthcare providers, recorded across 2,492 transactions in the CMS Open Payments database. The primary manufacturer is Seqirus USA Inc.
Payment data is available from 2021 to 2023. In 2023, $20,077 was paid across 921 transactions to 853 doctors.
The most common payment nature for Fluad Quadrivalent is "Unspecified" ($162,261, 74.3% of total).
Fluad Quadrivalent is associated with 2 research studies, including "A Phase 3, Randomized, Observer-blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine in Comparison With a Licensed Quadrivalent Influenza Vaccine, in Adults 50 to 64 Years of Age" ($159,261).